The effects of apelin treatment on a rat model of type 2 diabetes.

[1]  J. Gagliardino,et al.  Islet NADPH oxidase activity modulates β-cell mass and endocrine function in rats with fructose-induced oxidative stress. , 2014, Biochimica et biophysica acta.

[2]  Jon C. Aster,et al.  Robbins & Cotran Pathologic Basis of Disease , 2014 .

[3]  M. Islam,et al.  Anti-diabetic effects of the acetone fraction of Senna singueana stem bark in a type 2 diabetes rat model. , 2014, Journal of ethnopharmacology.

[4]  S. Turgut,et al.  Apelin Effects on Blood Pressure and RAS in DOCA-Salt-Induced Hypertensive Rats , 2013, Clinical and experimental hypertension.

[5]  H. Milnerowicz,et al.  The effect of endothelin-1 on pancreatic diseases in patients who smoke. , 2013, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[6]  A. Fukamizu,et al.  Apelin elevates blood pressure in ICR mice with L-NAME-induced endothelial dysfunction , 2013, Molecular medicine reports.

[7]  G. Erken,et al.  Blood Pressure Measurement in Freely Moving Rats by the Tail Cuff Method , 2013, Clinical and experimental hypertension.

[8]  A. B. Novaes,et al.  Arterial Hypertension Perpetuates Alveolar Bone Loss , 2013, Clinical and experimental hypertension.

[9]  I. Castan-Laurell,et al.  Apelin, a promising target for type 2 diabetes treatment? , 2012, Trends in Endocrinology & Metabolism.

[10]  J. Penninger,et al.  Apelin Treatment Increases Complete Fatty Acid Oxidation, Mitochondrial Oxidative Capacity, and Biogenesis in Muscle of Insulin-Resistant Mice , 2012, Diabetes.

[11]  A. Lochner,et al.  ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance , 2011, Molecular and Cellular Biochemistry.

[12]  A. Boulares,et al.  Angiotensin I–Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice , 2010, Diabetes.

[13]  Pascal G. P. Martin,et al.  Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. , 2010, American journal of physiology. Endocrinology and metabolism.

[14]  Xiaofang Fan,et al.  Low Plasma Apelin in Newly Diagnosed Type 2 Diabetes in Chinese People , 2009, Diabetes Care.

[15]  F. Tinahones,et al.  Apelin Levels Are Increased in Morbidly Obese Subjects with Type 2 Diabetes Mellitus , 2009, Obesity surgery.

[16]  S. Gogg,et al.  Increased MAPK Activation and Impaired Insulin Signaling in Subcutaneous Microvascular Endothelial Cells in Type 2 Diabetes: The Role of Endothelin-1 , 2009, Diabetes.

[17]  A. Leite-Moreira,et al.  Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. , 2009, American journal of physiology. Heart and circulatory physiology.

[18]  T. Reyes,et al.  Diminished Metabolic Responses to Centrally‐Administered Apelin‐13 in Diet‐Induced Obese Rats Fed a High‐Fat Diet , 2009, Journal of neuroendocrinology.

[19]  I. Castan-Laurell,et al.  Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. , 2008, Cell metabolism.

[20]  M. Kalani,et al.  The importance of endothelin-1 for microvascular dysfunction in diabetes , 2008, Vascular health and risk management.

[21]  T. McDonagh,et al.  The role of apelin in cardiovascular function and heart failure , 2008, European journal of heart failure.

[22]  A. Leite-Moreira,et al.  The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. , 2008, Arquivos brasileiros de cardiologia.

[23]  A. Sonmez,et al.  Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[24]  J. Speakman,et al.  Chronic Central Administration of Apelin‐13 Over 10 Days Increases Food Intake, Body Weight, Locomotor Activity and Body Temperature in C57BL/6 Mice , 2007, Journal of neuroendocrinology.

[25]  M. Yılmaz,et al.  Plasma Apelin is Lower in Patients with Elevated LDL-Cholesterol , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[26]  K. Higuchi,et al.  Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. , 2007, Endocrinology.

[27]  Yu Huang,et al.  Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. , 2007, Cardiovascular research.

[28]  Gangyi Yang,et al.  Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  B. Ahrén,et al.  The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice , 2005, Regulatory Peptides.

[30]  M. Quon,et al.  Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. , 2005, American journal of physiology. Heart and circulatory physiology.

[31]  T. Hintze,et al.  Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure: Enhanced Release of COX-2–Derived Constrictor Prostaglandins , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  J. Ai,et al.  Development of Wistar rat model of insulin resistance. , 2005, World journal of gastroenterology.

[33]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[34]  I. Castan-Laurell,et al.  Apelin, a newly identified adipokine up-regulated by insulin and obesity. , 2005, Endocrinology.

[35]  M. Iida,et al.  Central and peripheral cardiovascular actions of apelin in conscious rats , 2005, Regulatory Peptides.

[36]  K. Kamata,et al.  Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery , 2004, Peptides.

[37]  E. Imai,et al.  Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes , 2004, Journal of Clinical and Experimental Nephrology.

[38]  A. Beaudet,et al.  Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. , 2004, Endocrinology.

[39]  D. Batlle,et al.  Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination? , 2004, Hypertension.

[40]  D. Sunter,et al.  Intracerebroventricular injection of apelin-13 reduces food intake in the rat , 2003, Neuroscience Letters.

[41]  M. Morris,et al.  Inhibitory Effect of Apelin-12 on Nocturnal Food Intake in the Rat , 2003, Nutritional neuroscience.

[42]  Robert P. Davis,et al.  Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin , 2003, Journal of neurochemistry.

[43]  T. Ogihara,et al.  [Role of angiotensin in the metabolic syndrome and cardiovascular complications]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[44]  M. Palkovits,et al.  Distribution of apelin-synthesizing neurons in the adult rat brain , 2002, Neuroscience.

[45]  S. Bloom,et al.  The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. , 2002, Biochemical and biophysical research communications.

[46]  Xiao Man Yang,et al.  Hyperglycemia modulates angiotensinogen gene expression. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[47]  E. Schiffrin.  Role of endothelin-1 in hypertension and vascular disease. , 2001, American journal of hypertension.

[48]  M. Palkovits,et al.  Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain , 2001, Journal of neurochemistry.

[49]  O. Nishimura,et al.  Molecular and Functional Characteristics of APJ , 2000, The Journal of Biological Chemistry.

[50]  S. Murosaki,et al.  Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. , 1999, Biochimica et biophysica acta.

[51]  G. Gerosa,et al.  Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. , 1999, Circulation.

[52]  K. Takahashi,et al.  Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.

[53]  S. Turgut,et al.  Apelin-induced hemorheological alterations in DOCA-salt hypertensive rats. , 2014, Clinical hemorheology and microcirculation.

[54]  Y. Ba.  Establishment of type 2 diabetic animal model in Wistar rats , 2004 .

[55]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .